| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.84 | 0.0006 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.51 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |